???? Silencing Risk: Lepodisiran vs Lp(a)

6 Views
Published
???? New hope for high Lp(a)!

???? Lepodisiran, a long-acting siRNA, slashed Lp(a) by 94% with just 2 shots/year.

???? RNA precision meets cardiac prevention.

???? Silent killer, silenced.

#CardioTwitter #RNAtherapy #LipoproteinA
Category
Cardiology
Be the first to comment